Marketing Pharma & Health Weekly Editions for April 2023
- Marketing Pharma & Health Weekly - Thursday, April 27, 2023
- Medical Inventions Can Come From Unexpected Sources
- In First-Ever Brand Extension, Excedrin Launches Heady Supplements
- J&J Chalks Up Talcum Charge As Sales, Guidance Rise
- Poise Addresses Women's Health Concern
- Study: Big Pharma Avoids TikTok, Pinterest, Snapchat
- Physical Therapists Target Long-COVID Sufferers
- MegaFood Uses Digital Megaphone To Promote Supplements
- CVS Health Aims To Transform Healthcare Delivery
- Marketing Pharma & Health Weekly - Thursday, April 20, 2023
- Who Knew Female Trees Could Fight Allergies? Claritin Did
- J&J Chalks Up Talcum Charge As Sales, Guidance Rise
- Grumpy Auto Repair Guy With Shoulder Pain: Therabody Moves 'Real People'
- Baby Dove Aims To Close Black Maternal Health Gap
- Washington State Passes Health Privacy Law
- To Keep Growing, LensDirect Thinks Small
- Mayo Clinic Innovates In Health -- And Ad Production
- New Health Privacy Bill Restricts Mobile Ads In Washington State
- Marketing Pharma & Health Weekly - Thursday, April 13, 2023
- Amazon, Ad Council Reinforce Music's Power To Open Hearts
- Dove Joins Efforts To Protect Kids From Social Media
- PSA Stresses The 'Why' Of Cancer Research
- Parkinson's Rescue Inhaler Launches Targeted Streaming Commercial
- Chrysler Partners With Autism Society
- Clorox Sells Supplements D2C -- But Brands Themselves May Be For Sale
- Humorous 'Advice,' AI Apps Latest Tools To Combat Youth Vaping
- Chew On It! Merck's Bravecto Takes A Dog's-Eye View
- Marketing Pharma & Health Weekly - Thursday, April 6, 2023
- RX For Success: Documentary-Style NYU Langone Spots Track Winning Results
- Johnson & Johnson Proposes $8.9B Settlement Of Talcum Powder Lawsuits
- Two Spirits Brands Team To Fight Testicular Cancer
- Shelving Products: CPG, Beauty, OTC Health Sectors See Reduction In Consumer Spending
- This Nasal Spray Wants You To Feel Sexy Again
- Psychedelic Drug Maker Lucy (In The Sky?) Creates Mushroom Drug
- Newly OTC Astepro, Nasonex Fight Allergies With Spring Campaigns
